DI DONATO, SAMANTHA
 Distribuzione geografica
Continente #
NA - Nord America 410
EU - Europa 333
AS - Asia 120
AF - Africa 3
Totale 866
Nazione #
US - Stati Uniti d'America 410
RU - Federazione Russa 175
IE - Irlanda 40
IT - Italia 40
CN - Cina 31
HK - Hong Kong 28
SE - Svezia 28
SG - Singapore 28
PL - Polonia 26
JO - Giordania 19
IN - India 12
AT - Austria 5
CH - Svizzera 5
CI - Costa d'Avorio 3
ES - Italia 3
GB - Regno Unito 3
FI - Finlandia 2
NL - Olanda 2
NO - Norvegia 2
VN - Vietnam 2
DE - Germania 1
FR - Francia 1
Totale 866
Città #
Santa Clara 140
Dublin 40
Chandler 37
Fairfield 35
Warsaw 26
Singapore 25
Ashburn 21
Hong Kong 20
Woodbridge 15
Lawrence 13
Moscow 11
Seattle 11
Altamura 10
Florence 10
Mumbai 9
Shanghai 9
Houston 8
Ann Arbor 7
Buffalo 7
Princeton 7
Boston 6
Cambridge 6
San Diego 6
Bern 5
Rome 5
Vienna 5
Boardman 4
New York 4
Wilmington 4
Abidjan 3
Barcelona 3
Beijing 3
Pune 3
Dearborn 2
Dong Ket 2
Helsinki 2
Kent 2
Medford 2
Nanjing 2
Oslo 2
Pescara 2
Prad am Stilfser Joch 2
Redwood City 2
Taranto 2
Bagno a Ripoli 1
Brentford 1
Falls Church 1
Hefei 1
Hillsboro 1
Impruneta 1
London 1
Los Angeles 1
Munich 1
Naaldwijk 1
Norwalk 1
Weitang 1
Yubileyny 1
Totale 553
Nome #
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial 134
D20Serum metabolomic as biomarkers to differentiate early from metastatic disease in elderly colorectal cancer (crc) patients 118
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study 90
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study 79
Outcomes of advanced gastric cancer patients treated with at least three lines of systemic chemotherapy 77
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world 76
Results of the observational prospective RealFLOT study 73
Exploring serum nmr-based metabolomic fingerprint of colorectal cancer patients: Effects of surgery and possible associations with cancer relapse 68
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough 48
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram 47
Erratum to: Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy (The Oncologist, (2017), 22, 12, (1463-1469), 10.1634/theoncologist.2017-0158) 42
Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancer 35
Totale 887
Categoria #
all - tutte 3.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.514


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202033 0 0 0 0 2 3 4 2 2 1 19 0
2020/202178 13 4 12 7 2 5 4 11 2 13 2 3
2021/202244 0 0 6 1 1 0 2 5 1 1 13 14
2022/2023210 9 33 8 10 12 38 27 36 28 0 4 5
2023/2024100 2 7 9 6 6 19 0 24 5 6 9 7
2024/2025399 28 72 31 100 168 0 0 0 0 0 0 0
Totale 887